HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy. - Wikidata - wikimedia - TriplyDB

HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy.

HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy.

http://www.wikidata.org/entity/Q33333436

about

The pathophysiology of thrombocytopenia in chronic liver disease Risk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus Infection Treatment of hepatitis C related thrombocytopenia with interferon alpha.Steroid-refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection.Thrombopoietin serum levels do not correlate with thrombocytopenia in hepatic schistosomiasis.Hematologic disorders associated with hepatitis C virus infection and their management.Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura.Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C.Overwhelming postsplenectomy infection syndrome in adults - a clinically preventable disease.Autoimmune thrombocytopenia related to chronic hepatitis C virus infection.Thrombocytopenia in patients with chronic hepatitis C: a possible role of HCV on platelet progenitor cell maturation.Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag.Pathobiology and treatment of hepatitis virus-related thrombocytopenia.Immune thrombocytopenia: no longer 'idiopathic'.Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet counts Immunological HCV-associated thrombocytopenia: short review Immunological alterations in hepatitis C virus infection.The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report Management of thrombocytopenia due to liver cirrhosis: a review The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Hepatitis C virus infection among patients with chronic immune thrombocytopenic purpura in northern India.Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy.Helicobacter pylori infection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: A multicenter, observational study.Thrombocytopenia in chronic liver disease.Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis C Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus).Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis.Hepatitis C virus and autoimmunity.Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy.The molecular prevalence of viral infections in transplant candidates with bone marrow suppression, shiraz, southern iran, 2010.Hepatitis C virus-related adult chronic idiopathic thrombocytopenic purpura: experience from a single Chinese center.Treatment Related Hematologic Changes in a Population of Iranian Patients with Chronic Hepatitis C Infection from 2009 to 2014.Platelets as Modulators of Liver Diseases.

P2860

Q26749277-8914B5FF-0E81-4AAE-A0EF-73AB5607F5F7 Q27490427-F2BAD423-8B85-42E0-B432-6250B9D3DE94 Q33340288-A610FCFF-B867-4CF7-AF72-87417A3CC244 Q33341932-AA8001D4-6FC0-474B-86DB-56941C93305A Q33342562-864D15BC-6910-4726-946D-C9B5A6A291A4 Q33349378-D4643D9C-FE61-41CF-A353-025D59EA289B Q33366747-CDE5AB96-9F93-46E7-99C7-059337EBE737 Q33372361-72F2174D-D554-4D55-9531-9FA6822FCD2A Q33378222-5142E0CC-467B-48EC-A1D0-A4820D2CB8CD Q33382854-C6AC9245-FF31-4F9C-84C4-9B47979BAA26 Q33385876-547CA7DE-02D9-40FD-88E3-1BCDE285BF57 Q33387808-A74EFBF5-06C3-4D8E-8E4C-7536B75170FE Q33394547-2E6B4AA1-A67E-4ECC-8A2D-A470A728089D Q33395624-6BB10204-90E9-4534-B1A6-39E7257ECB8C Q33399240-F9EFF3B8-611F-4C10-94C3-17608D454FC2 Q33402517-4B21D751-DD9C-43B0-8FA9-7733F0A98614 Q33412382-47A845AD-5B53-424C-A319-EC71114C05B3 Q33412844-573C577B-1822-414E-8383-8E567C32EEF3 Q33413924-9DA179EA-3C1B-42BF-992B-E7F5CED36CC8 Q33414386-C4A3E6E0-803F-422E-A25D-3FDF2456690C Q33421032-D47EFEB2-029A-4572-A7AA-9C342F646121 Q33421239-BAF3FDF0-0413-4E4A-8BE7-30A8EB0827B4 Q33425621-2A488EB6-E5F4-43FA-B2CF-C0A029B3B065 Q33436905-C920D1FB-1780-4B69-9A87-92F5586431D0 Q36178690-03F864CA-80DB-436C-894F-FC22098FC0C8 Q36248995-BDCC9932-7554-4444-88E0-513A443AC278 Q38368635-6C96D2DE-C022-456A-AF28-6718A04E3D66 Q38497354-609AAF52-F224-48F2-A8D8-FA6277680547 Q39854779-6A790762-D6B4-437E-A110-FD26F5DB08A9 Q42727267-DABE2990-8613-4A9F-AA1D-7CE6DB0A5EC2 Q43049522-F8C6BB20-C5A9-4441-842F-6FC18F9C28B6 Q47199643-58D94E35-2C51-4758-A7F4-C124A3A90897 Q50131013-5B37793E-E468-4670-8265-E3227AD92756

P2860

HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy.

http://www.wikidata.org/entity/Q33333436

description

2000 nî lūn-bûn

@nan

2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

HCV-associated thrombocytopeni ...... nt alpha2b-interferon therapy.

@ast

HCV-associated thrombocytopeni ...... nt alpha2b-interferon therapy.

@en

HCV-associated thrombocytopeni ...... nt alpha2b-interferon therapy.

@nl

type

label

HCV-associated thrombocytopeni ...... nt alpha2b-interferon therapy.

@ast

HCV-associated thrombocytopeni ...... nt alpha2b-interferon therapy.

@en

HCV-associated thrombocytopeni ...... nt alpha2b-interferon therapy.

@nl

prefLabel

HCV-associated thrombocytopeni ...... nt alpha2b-interferon therapy.

@ast

HCV-associated thrombocytopeni ...... nt alpha2b-interferon therapy.

@en

HCV-associated thrombocytopeni ...... nt alpha2b-interferon therapy.

@nl

P1433

Q33333436-96467437-6D28-4B53-80DF-47DEE77A6571

P1476

Q33333436-3086DDB9-AEDC-48EE-87EC-BB14A1DB3189

P2093

Q33333436-0D0FF63D-6B65-4403-85DF-B9E67BE4AB67

Q33333436-2F03561E-CBFF-4B1A-9BD9-09CDB7F1D759

Q33333436-48F97269-0683-4DDC-B4A1-D13DADBEEA47

Q33333436-8BDC79FD-9F26-4B42-B52C-56DD6F75C60C

Q33333436-9867B0C3-F4EB-4B93-969F-D69E9BB8F284

Q33333436-D6B27CE7-E018-4297-87EC-7B2C983520B8

P2860

Q33333436-2C3EADD2-DABC-4244-8C59-26D06DD65F33

Q33333436-76F162A0-8A23-414C-ACFA-5128290B4449

Q33333436-990AC081-80D3-4EE2-AEA2-54B3FC3147B6

Q33333436-A74BAFAC-EB30-4AAB-940D-B9F172D76BAE

Q33333436-B52E1B38-FD88-4DD7-859E-31FBDC2945A3

Q33333436-ED0F30A8-9280-4841-B6BE-A370C909CCAE

Q33333436-FD4E2AE2-0DF5-4DD3-A086-5BAA51ABD433

P304

Q33333436-E661FE44-F275-4D5D-8F1F-047C1B153C86

P31

Q33333436-24C4969D-DE5B-4D3B-92AE-AF571979B2A6

P356

Q33333436-14C8D45C-B56A-4684-886F-80CB2F3F7B3E

P407

Q33333436-8D02025C-E427-4486-9680-47A9B2EBD794

P433

Q33333436-CBD9C7A2-E929-4EEC-A887-19BBD5424536

P478

Q33333436-85755269-50C8-41CE-B8D3-E5B06B14DDF6

P577

Q33333436-7B874850-843C-43FE-942C-32EE468B3E83

P5875

Q33333436-83FC89B7-1933-4FCA-9D85-455841D13290

P698

Q33333436-95AFA8ED-6AF7-4A1C-BCDF-8153123A6273

P921

Q33333436-DD46964D-D98E-449E-ABA6-F2AC0D81261F

P356

J.1365-2141.2000.02132.X

P1433

British Journal of Haematology

P1476

HCV-associated thrombocytopeni ...... nt alpha2b-interferon therapy.

@en

P2093

C Burgaleta

http://www.w3.org/2001/XMLSchema#string

F Albarran

http://www.w3.org/2001/XMLSchema#string

J García-Suárez

http://www.w3.org/2001/XMLSchema#string

M Alvarez-Mon

http://www.w3.org/2001/XMLSchema#string

N Hernanz

http://www.w3.org/2001/XMLSchema#string

P Tobaruela

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus infection and autoimmune thrombocytopenic purpura.

Thrombocytopenia associated with hepatitis C viral infection.

Side effects of alpha interferon in chronic hepatitis C.

Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells.

Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment.

Autoimmune thrombocytopenia and hepatitis C virus infection.

Alpha interferon therapy in thrombocytopenia associated with hepatitis C virus infection.

P304

98-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2141.2000.02132.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2000-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12389604

http://www.w3.org/2001/XMLSchema#string

P698

10930984

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia